Suchergebnisse - "Byrd, John"

PubPharm (1.294)

91

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies : A Phase I Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Stephens, D. | Huang, Y. | Ruppert, A. | +15

92

Subclonal evolution of CLL driver mutations is associated with relapse in ibrutinib- and acalabrutinib-treated patients

enthalten in: Blood | 2022

von Black, G. | Huang, X. | Qiao, Y. | +7

93

Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivity

enthalten in: Cell reports | 2022

von Chiang, C. | Hu, E. | Chang, L. | +19

94

Methods and compositions for inhibition of dihydroorotate dehydrogenase

enthalten in: Europäisches Patentamt | 2022

von BYRD JOHN C | BENNETT CHAD E | VIBHUTE SANDIP MADHUKAR | +4

95

Methods and compositions for inhibition of dihydroorotate dehydrogenase in combination with an anti-CD38 therapeutic agent

enthalten in: Europäisches Patentamt | 2022

von BYRD JOHN C | HERTLEIN ERIN | ELGAMAL OLA A | +5

96

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

enthalten in: Journal of hematology & oncology | 2022

von Chen, S. | Azali, L. | Rosen, L. | +15

97

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

enthalten in: Journal of hematology & oncology | 2022

von Chen, S. | Azali, L. | Rosen, L. | +15

98

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

enthalten in: Journal of hematology & oncology | 2022

von Chen, S. | Azali, L. | Rosen, L. | +15

99

DNA Origami Nanostructures Elicit Dose-Dependent Immunogenicity and Are Nontoxic up to High Doses In Vivo

enthalten in: Small (Weinheim an der Bergstrasse, Germany) | 2022

von Lucas, C. | Halley, P. | Chowdury, A. | +8

100

ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia

enthalten in: Leukemia research | 2022

von Goswami, S. | Chiang, C. | Zapolnik, K. | +11